Osborn Williams & Donohoe’s Labcorp LH Stock Holding History

Osborn Williams & Donohoe’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-236	Closed	-$32K	–	513
2019 Q1	$32K	Buy	+236	New	+$29.1K	﹤0.01%	517

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Osborn Williams & Donohoe's LH Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Labcorp (LH) in Q2 2019, closing a stake of 236 shares — an estimated $32K sold.

Osborn Williams & Donohoe first reported a position in LH in Q1 2019 and held it in 1 quarter. The position peaked at $32K in Q1 2019. 741 funds tracked by Wall St. Rank hold LH as of Q2 2019.

Osborn Williams & Donohoe reported no remaining Labcorp position as of Q2 2019 after selling out during the quarter.
Osborn Williams & Donohoe sold 236 Labcorp shares in Q2 2019, an estimated $32K.
Osborn Williams & Donohoe first reported a position in Labcorp in Q1 2019 and held it in 1 quarter.
Osborn Williams & Donohoe's Labcorp position peaked at $32K in Q1 2019.
741 funds tracked by Wall St. Rank held Labcorp as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.